These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9805981)

  • 1. [Correct use of serotonin agonists in migraine: oral or injectable form?].
    Joffroy A
    Rev Med Brux; 1998 Sep; 19(4):A393-7. PubMed ID: 9805981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines.
    Friedman BW; Hochberg M; Esses D; Bijur PE; Corbo J; Paternoster J; Solorzano C; Toosi B; Lipton RB; Gallagher EJ
    Headache; 2006 Jun; 46(6):934-41. PubMed ID: 16732839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient information regarding subcutaneous self-administration of sumatriptan (imitrex).
    Rothrock JF
    Headache; 2007 Apr; 47(4):639. PubMed ID: 17445120
    [No Abstract]   [Full Text] [Related]  

  • 4. Defining optimal dosing for sumatriptan tablets in the acute treatment of migraine.
    Mathew NT; Salonen R
    Int J Clin Pract Suppl; 1999 Aug; 105():2-6. PubMed ID: 10692716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable sumatriptan: now needle-based or needle-free.
    Rothrock JF
    Headache; 2010 Feb; 50(2):343-4. PubMed ID: 20456140
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
    Dowson AJ; Ashford EA; Prendergast S; Hassani H; Roberts GW; Flöter T; Szczudlik A
    Int J Clin Pract Suppl; 1999 Aug; 105():25-33. PubMed ID: 10692719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixing sumatriptan: a prospective study of stratified care using multiple formulations.
    Kaniecki RG
    Headache; 2001 Oct; 41(9):862-6. PubMed ID: 11703472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
    Salonen R; Ashford EA; Gibbs M; Hassani H
    Int J Clin Pract Suppl; 1999 Aug; 105():16-24. PubMed ID: 10692718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ; Charlesworth BR
    Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials.
    Tfelt-Hansen P; Ryan RE
    Neurology; 2000; 55(9 Suppl 2):S19-24. PubMed ID: 11089515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
    Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
    Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.
    Landy SH; McGinnis JE; McDonald SA
    Headache; 2005 Apr; 45(4):346-9. PubMed ID: 15836571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic treatment of acute migraine attack in children].
    Cuvellier JC; Joriot S; Auvin S; Vallée L
    Arch Pediatr; 2005 Mar; 12(3):316-25. PubMed ID: 15734131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal].
    Félix JM; Inês MS; Acosta CM
    Acta Med Port; 2005; 18(1):77-87. PubMed ID: 16202337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
    Cutrer FM; Goadsby PJ; Ferrari MD; Lipton RB; Dodick DW; McCrory D; Williams P
    Clin Ther; 2004 Sep; 26(9):1533-45. PubMed ID: 15531016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fixed-dose combination of sumatriptan and naproxen for migraine.
    Med Lett Drugs Ther; 2008 Jun; 50(1288):45-6. PubMed ID: 18551089
    [No Abstract]   [Full Text] [Related]  

  • 20. [Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
    Tfelt-Hansen P; Iversen HK
    Ugeskr Laeger; 2006 May; 168(19):1850-3. PubMed ID: 16756800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.